Ellen: 1.5m SEK

Case

The innovative biotech company Ellen AB was granted SEK 1.5 million from Vinnova for a development project in vaginal hygiene.

“We needed funding for a critical project in biotechnology. One success factor for us in the grant process was the relief offered by GAEU Consulting services.”

- Monica Wallter, CEO

Previous
Previous

Surgical Science: 2.5m SEK

Next
Next

Aerocrine: 1.5m SEK